Genor Biopharma Co.
Latest round
- Series B
Last raised
- Jun 2020
Total raised
- $160M
Investors
- 4
About Genor Biopharma Co.
,Ltd.,Ltd. specializes in biopharmaceutical development and was founded in 2007 in Shanghai, China.00 mn from Edding Genor Group Holdings Limited. The firm has completed a total of 9 deals, with the most recent deal dated October 7, 2020.Genor Biopharma Co. Ltd specializes in developing and commercializing biopharmaceutical products, particularly innovative monoclonal antibody therapies aimed at treating diseases such as cancer and autoimmune disorders. Their products are designed to engage specific biological targets to enhance therapeutic efficacy while minimizing adverse effects.In 2020, Genor Biopharma Co.Genor Biopharma Co. Ltd plans to launch new products focused on innovative monoclonal antibodies, with specific details expected in upcoming announcements. The company aims to expand into new markets, particularly in Europe and North America, by the end of 2023.8776 billion, will support these initiatives and enhance their product pipeline in preparation for broader market entry.
Who invested in Genor Biopharma Co.
4 investors across 1 round
See all investors in Genor Biopharma Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jun 1, 2020
Amount
$160M
Investors
Questions about Genor Biopharma Co.
Who invested in Genor Biopharma Co.?
Genor Biopharma Co. has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Genor Biopharma Co. raised?
Genor Biopharma Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Genor Biopharma Co. last raise money?
Genor Biopharma Co.'s most recent round on record is a Series B, in Jun 2020.
What does Genor Biopharma Co. do?
Genor Biopharma Co. is a biotechnology company.
Where is Genor Biopharma Co. headquartered?
Genor Biopharma Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Genor Biopharma Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Genor Biopharma Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Genor Biopharma Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.